ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 571,56
-0,80%
Dow Jones
40 211,72
0,53%
DAX
18 500,82
-0,53%
Brent Oil
83,165
-1,39%
Bitcoin
63 702,25
-1,77%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
23/12/201609h02Dow Jones NewsTeva Settles Charges in U.S. -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
23/12/201600h28Dow Jones NewsADRs End LowerNYSE:TEVATeva Pharmaceutical Industries Ltd
22/12/201621h48Dow Jones NewsTeva Settles Foreign Corruption Probe for $519 Million -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
22/12/201618h05Dow Jones NewsTeva Settles Foreign Corruption Probe for $519 Million--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
22/12/201616h31Dow Jones NewsTeva Settles Foreign Corruption Probe for $519 millionNYSE:TEVATeva Pharmaceutical Industries Ltd
22/12/201615h24Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
22/12/201615h15Business WireTeva Reaches Settlement with Government on FCPANYSE:TEVATeva Pharmaceutical Industries Ltd
17/12/201613h05PR Newswire (US)SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Teva Phar...NYSE:TEVATeva Pharmaceutical Industries Ltd
17/12/201604h50Business WireTEVA SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess o...NYSE:TEVATeva Pharmaceutical Industries Ltd
14/12/201620h28Business WireGlancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Teva Pharmaceuticals Investors & E...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/12/201604h00Business WireDEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Lo...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/12/201615h05Business WireTeva to Present at the Citi 2016 Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
06/12/201612h30Business WireTeva reçoit un avis positif pour l'étiquette du COPAXONE® en EuropeNYSE:TEVATeva Pharmaceutical Industries Ltd
06/12/201608h00Business WireTeva erzielt positives Ergebnis für Etikett von COPAXONE® in EuropaNYSE:TEVATeva Pharmaceutical Industries Ltd
06/12/201608h00Business WireTeva Receives Positive Outcome for COPAXONE® Label in EuropeNYSE:TEVATeva Pharmaceutical Industries Ltd
05/12/201622h01Business WireTeva Appoints Dipankar Bhattacharjee as President & Chief Executive Officer, Global Generic Medicines Group, Succeeding Siggi...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/12/201604h07PR Newswire (US)TEVA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds INSTITUTIONAL Investors with Loss...NYSE:TEVATeva Pharmaceutical Industries Ltd
30/11/201614h00Business WireTeva to Present Oncology Data at the 2016 American Society of Hematology (ASH) Annual Meeting & ExpositionNYSE:TEVATeva Pharmaceutical Industries Ltd
23/11/201615h58Business WireTeva Pharmaceutical Industries Limited Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Fi...NYSE:TEVATeva Pharmaceutical Industries Ltd
21/11/201608h00Business WireTeva Secures European Approval of Trisenox® for First Line Treatment of Low to Intermediate Risk Acute Promyelocytic Leukemi...NYSE:TEVATeva Pharmaceutical Industries Ltd
19/11/201605h45Business WireINVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Teva Pharmaceut...NYSE:TEVATeva Pharmaceutical Industries Ltd
19/11/201602h12PR Newswire (US)SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceutical Industries...NYSE:TEVATeva Pharmaceutical Industries Ltd
17/11/201614h30PR Newswire (US)Biotech Stocks Press Forward with Drug-Development AdvancementsNYSE:TEVATeva Pharmaceutical Industries Ltd
16/11/201620h40Business WireThe Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Teva Pharmaceuticals Invest...NYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201620h18Business WireRobbins Arroyo LLP: Teva Pharmaceutical Industries Ltd. (TEVA) Misled Shareholders According to a Recently Filed Class ActionNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201616h01Dow Jones NewsTeva Revenue Rises on Allergan Deal -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201615h59Dow Jones NewsCorrection to Teva Earnings StoryNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201615h00Dow Jones NewsTeva Revenue Rises on Allergan DealNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201614h40Dow Jones NewsTeva Revenue Rises on Allergan Deal, But Its Specialty Drugs Saw PressureNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201613h00Business WireTeva Reports Third Quarter 2016 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
DG
Vinci
USI
USTECH100
US Tech 100
NYSE
MCD
McDonalds
EU
RI
Pernod Ricard
NYSE
JPM
JP Morgan Chase
EU
PX4
SBF 120
EU
BEL20
Bel 20
EU
CS
Axa
NASDAQ
AAPL
Apple
FTSE
UKX
FTSE 100
EU
BN
Danone
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés